XML 37 R23.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Share-based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-based Compensation | Share-based Compensation At December 31, 2018, we had two incentive plans; the 2007 Equity Compensation Plan (the “2007 Plan”) which replaced our 2000 plan and the 2013 Equity Compensation Plan (the “2013 Plan” and with 2007 Plan, the “Plans”) which replaced the 2007 Plan. The 2013 Plan provides awards of options, stock appreciation rights, restricted stock awards, restricted stock unit awards, shares granted as a bonus or in lieu of another award, dividend equivalent, other stock-based award or performance award, together with any other right or interest to a participant under the plan. Plan participants include executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its related entities. Although no future stock options may be granted under the earlier plans, certain employees, directors and officers of Hanmi Financial and its subsidiaries still hold options to purchase Hanmi Financial common stock under the 2007 and 2013 Plans. Under the 2013 Plan, we may grant equity incentive awards for up to 1,500,000 shares of common stock. As of December 31, 2018, 440,055 shares were still available for issuance under the 2013 Plan. The Company adopted ASU 2016-09, Compensation - Stock Compensation, during the three months ended March 31, 2016. Adoption of this ASU did not have a material impact on the Company's financial statements. Excess tax benefits related to the Company's share-based compensation were recognized as income tax expense in the consolidated statement of income for the three years ended December 31, 2018. The table below provides the share-based compensation expense and related tax benefits for the periods indicated:
| Year Ended December 31,
| 2018 |  | 2017 |  | 2016
| (in thousands)
Share-based compensation expense | $ | 3,515 |  |  | $ | 2,893 |  |  | $ | 3,008 |
Related tax benefits | $ | 984 |  |  | $ | 1,179 |  |  | $ | 1,191 |
As of December 31, 2018, unrecognized share-based compensation expense was as follows
| Unrecognized Expense |  | Average Expected Recognition Period
| (in thousands) |  |
Restricted stock awards | $ | 4,306 |  |  | 1.9 years
Total unrecognized share-based compensation expense | $ | 4,306 |  |  | 1.9 years
2013 and 2007 Equity Compensation Plans Stock Options All stock options granted under the Plans have an exercise price equal to the fair market value of the underlying common stock on the date of grant. Stock options granted under the Plans generally vest based on three to five years of continuous service and expire 10 years from the date of grant. Certain option and share awards provide for accelerated vesting if there is a change in control (as defined in the Plans). New shares of common stock are issued or treasury shares are utilized upon the exercise of stock options. There were no options granted during the three years ended December 31, 2018. The following information under the Plans is presented for the periods indicated:
| Year Ended December 31,
| 2018 |  | 2017 |  | 2016
| (in thousands, except per share data)
Fair value of options vested | $ | 184 |  |  | $ | 820 |  |  | $ | 2,322 |
Total intrinsic value of options exercised (1) | $ | — |  |  | $ | 432 |  |  | $ | 1,862 |
Cash received from options exercised | $ | — |  |  | $ | 288 |  |  | $ | 1,453 |
(1) | Intrinsic value represents the difference between the closing stock price on the exercise date and the exercise price, multiplied by the number of options.
The following is a summary of stock option transactions under the Plans for the periods indicated:
| Year Ended December 31,
| 2018 |  | 2017 |  | 2016
| Number of Shares |  | Weighted- Average Exercise Price Per Share |  | Number of Shares |  | Weighted- Average Exercise Price Per Share |  | Number of Shares |  | Weighted- Average Exercise Price Per Share
Options outstanding at beginning of period | 364,088 |  |  | $ | 17.86 |  |  | 387,901 |  |  | $ | 17.49 |  |  | 510,148 |  |  | $ | 24.38 |
Options exercised | (25,750 | ) |  | $ | 22.06 |  |  | (23,813 | ) |  | $ | 12.21 |  |  | (94,997 | ) |  | $ | 15.29 |
Options forfeited | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | (125 | ) |  | $ | 144.00 |
Options expired | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | (27,125 | ) |  | $ | 154.09 |
Options outstanding at end of period | 338,338 |  |  | $ | 17.52 |  |  | 364,088 |  |  | $ | 17.86 |  |  | 387,901 |  |  | $ | 17.49 |
Options exercisable at end of period | 338,338 |  |  | $ | 17.52 |  |  | 354,753 |  |  | $ | 17.71 |  |  | 341,561 |  |  | $ | 16.85 |
The following is a summary of transactions for non-vested stock options under the Plans for the periods indicated:
| Year Ended December 31,
| 2018 |  | 2017 |  | 2016
| Number of Shares |  | Weighted- Average Exercise Price Per Share |  | Number of Shares |  | Weighted- Average Exercise Price Per Share |  | Number of Shares |  | Weighted- Average Exercise Price Per Share
Non-vested options outstanding at beginning of period | 9,335 |  |  | $ | 23.47 |  |  | 46,340 |  |  | $ | 22.42 |  |  | 176,688 |  |  | $ | 19.13 |
Options vested | (9,335 | ) |  | $ | 23.47 |  |  | (37,005 | ) |  | $ | 22.16 |  |  | (130,223 | ) |  | $ | 17.83 |
Options forfeited | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | (125 | ) |  | $ | 144.00 |
Non-vested options outstanding at end of period | — |  |  | $ | — |  |  | 9,335 |  |  | $ | 23.47 |  |  | 46,340 |  |  | $ | 22.42 |
As of December 31, 2018, stock options outstanding under the Plans were as follows:
|  | Options Outstanding |  | Options Exercisable
Range of Exercise Prices |  | Number of Shares |  | Intrinsic Value (1) |  | Weighted- Average Exercise Price Per Share |  | Weighted- Average Remaining Contractual Life |  | Number of Shares |  | Intrinsic Value (1) |  | Weighted- Average Exercise Price Per Share |  | Weighted- Average Remaining Contractual Life
|  |  |  |  |  | (in thousands except share and per share data) |  |  |  |
$10.80 to $14.99 |  | 12,338 |  |  | $ | 90 |  |  | $ | 12.36 |  |  | 3.6 years |  | 12,338 |  |  | $ | 90 |  |  | $ | 12.36 |  |  | 3.6 years
$15.00 to $19.99 |  | 265,000 |  |  | 834 |  |  | 16.55 |  |  | 4.7 years |  | 265,000 |  |  | 834 |  |  | 16.55 |  |  | 4.7 years
$20.00 to $24.83 |  | 61,000 |  |  | — |  |  | 22.73 |  |  | 5.8 years |  | 61,000 |  |  | — |  |  | 22.73 |  |  | 5.8 years
|  | 338,338 |  |  | $ | 924 |  |  | $ | 17.52 |  |  |  |  | 338,338 |  |  | $ | 924 |  |  | $ | 17.52 |  |  |
(1) | Intrinsic value represents the difference between the closing stock price on the last trading day of the period, which was $19.70 as of December 31, 2018, and the exercise price, multiplied by the number of options.
Restricted Stock Awards Restricted stock awards under the Plans become fully vested after a certain number of years or after certain performance criteria are met. Hanmi Financial becomes entitled to an income tax deduction in an amount equal to the taxable income reported by the holders of the restricted shares when the restrictions are released and the shares are issued. Restricted shares are forfeited if officers and employees terminate prior to the lapsing of restrictions. Forfeitures of restricted stock are treated as canceled shares. The table below provides information for restricted stock awards under the 2013 Plan for the periods indicated:
| 2018 |  | 2017 |  | 2016
| Number of Shares |  | Weighted- Average Grant Date Fair Value Per Share |  | Number of Shares |  | Weighted- Average Grant Date Fair Value Per Share |  | Number of Shares |  | Weighted- Average Grant Date Fair Value Per Share
Restricted stock at beginning of period | 317,783 |  |  | $ | 21.09 |  |  | 343,958 |  |  | $ | 16.60 |  |  | 137,114 |  |  | $ | 20.74 |
Restricted stock granted | 156,771 |  |  | $ | 25.02 |  |  | 127,239 |  |  | $ | 31.06 |  |  | 287,179 |  |  | $ | 15.52 |
Restricted stock vested | (106,674 | ) |  | $ | 27.11 |  |  | (139,298 | ) |  | $ | 18.73 |  |  | (77,515 | ) |  | $ | 19.75 |
Restricted stock forfeited | (63,285 | ) |  | $ | 15.38 |  |  | (14,116 | ) |  | $ | 24.73 |  |  | (2,820 | ) |  | $ | 21.58 |
Restricted stock at end of period | 304,595 |  |  | $ | 21.98 |  |  | 317,783 |  |  | $ | 21.09 |  |  | 343,958 |  |  | $ | 16.60 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration